Life Sciences

Natick healthcare firm Allurion Technologies has rebranded its products to integrate its weight-loss balloon that doesn't require surgery and passes naturally through the body with a weight-loss program with a digital app.

New York City pharmaceutical giant Bristol Myers Squibb has selected the head of Sanofi Pasteur's biologics manufacturing to be the new general manager of its expanding facility in Devens.

Marlborough medical device company CardioFocus has announced the appointment of Stephan Ogilvie as its chief financial officer.

The U.S. Department of Commerce announced on Thursday its Department of Economic Development Administration is awarding a $1.3-million grant to the City of Worcester for infrastructure improvements needed to support The Reactory biomanufacturing park.

Milford life sciences company Waters Corp. has named Bayer Group China President Wei Jiang to its board of directors.

Boston Scientific, a medical device manufacturer based in Marlborough, has announced it will purchase the remaining shares of Farapulse, Inc. for a total purchase amount of up to $575 million.

Marlborough medical device company CardioFocus has announced the Japanese Ministry of Health, Labor and Welfare has approved the company's HeartLight X3 System for marketing in Japan.

In a move Marlborough medical device manufacturer Hologic says will open the treatment up to millions of women, insurance provider Cigna has updated its policy to cover the Acessa Laparoscopic Radiofrequency Ablation procedure as medically necessary.

Southborough life sciences firm Veristat announced on Wednesday Colleen Pelton has been appointed to the role of chief talent officer.

Marlborough medical device company CardioFocus announced on Wednesday it has entered into a $20-million agreement with a Chinese firm for a license to produce and distribute its catheter ablation HeartLight X3 System.